Back

Viral respiratory tract infections in heart failure with mildly reduced and preserved ejection fraction: a secondary analysis of the FINEARTS-HF trial

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: The changing landscape of heart failure Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ragnhild Helseth

Brigham and Women's Hospital, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
Integrating body mass index and waist-to-hip ratio identifies the 'lemon-on-sticks' phenotype as a high-risk subgroup in heart failure
Miss C. van der Hoef (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Clustering patterns of evidence-based therapy identifies distinct phenotypes in heart failure with reduced ejection fraction: a machine learning analysis of the Swedish heart failure registry
Assistant Professor A. Uijl (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Evolving trends in treatments, morbidity, and mortality in heart failure: 30 years of data from the italian network of heart failure (IN-HF) registry
Professor A. Maggioni (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Trends in heart failure etiologies and comorbidities: a nationwide analysis of 700,000 individuals over two decades
Doctor D. Lindholm (Norrtalje, SE)
Abstract Slides Video
Presentation thumbnail
Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions
Doctor A. Agharahmanian (San Francisco, US)
Abstract Slides Video

Access the full session

Session thumbnail
The changing landscape of heart failure
Video

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
New tools to detect and treat acute heart failure
thumbnail
Congress Presentation
FINEARTS-HF: new paths to improve outcomes in heart failure
thumbnail
Congress Presentation
Simultaneous vaccination against influenza and respiratory syncytial virus in high-risk heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources